1. Home
  2. NVCR vs AIR Comparison

NVCR vs AIR Comparison

Compare NVCR & AIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • AIR
  • Stock Information
  • Founded
  • NVCR 2000
  • AIR 1951
  • Country
  • NVCR Switzerland
  • AIR United States
  • Employees
  • NVCR N/A
  • AIR N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • AIR Aerospace
  • Sector
  • NVCR Health Care
  • AIR Industrials
  • Exchange
  • NVCR Nasdaq
  • AIR Nasdaq
  • Market Cap
  • NVCR 1.9B
  • AIR 2.0B
  • IPO Year
  • NVCR 2015
  • AIR 1988
  • Fundamental
  • Price
  • NVCR $17.44
  • AIR $59.62
  • Analyst Decision
  • NVCR Buy
  • AIR Strong Buy
  • Analyst Count
  • NVCR 6
  • AIR 6
  • Target Price
  • NVCR $32.83
  • AIR $80.67
  • AVG Volume (30 Days)
  • NVCR 861.0K
  • AIR 247.0K
  • Earning Date
  • NVCR 04-24-2025
  • AIR 03-27-2025
  • Dividend Yield
  • NVCR N/A
  • AIR N/A
  • EPS Growth
  • NVCR N/A
  • AIR N/A
  • EPS
  • NVCR N/A
  • AIR N/A
  • Revenue
  • NVCR $621,711,000.00
  • AIR $2,682,500,000.00
  • Revenue This Year
  • NVCR $2.90
  • AIR $18.46
  • Revenue Next Year
  • NVCR $10.47
  • AIR $5.10
  • P/E Ratio
  • NVCR N/A
  • AIR N/A
  • Revenue Growth
  • NVCR 18.27
  • AIR 21.07
  • 52 Week Low
  • NVCR $14.17
  • AIR $46.51
  • 52 Week High
  • NVCR $34.13
  • AIR $76.34
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 48.61
  • AIR 61.75
  • Support Level
  • NVCR $16.19
  • AIR $52.49
  • Resistance Level
  • NVCR $18.52
  • AIR $57.32
  • Average True Range (ATR)
  • NVCR 0.85
  • AIR 1.59
  • MACD
  • NVCR 0.06
  • AIR 1.22
  • Stochastic Oscillator
  • NVCR 54.82
  • AIR 94.25

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About AIR AAR Corp.

AAR Corp is engaged in providing products and services to aviation, government, and defense market. It operates in three segments namely Parts Supply, Repair & Engineering, and Integrated Solutions. The parts supply segment majorly consists of sales and leasing of USM and aftermarket distribution of new, OEM-supplied replacement parts. Repair & Engineering segment provides airframe maintenance, component repair, and landing gear overhaul services. Integrated Solutions segment majorly consists of its fleet management and operations of customer-owned aircraft, customized performance-based supply chain logistics programs in support of the U.S. Department of Defense and foreign governments, flight hour component inventory and repair programs for commercial airlines.

Share on Social Networks: